Table 2.

ASCVD event rates in relationship to detectable and undetectable hs-cTnT and CAC for the entire cohort and by sex.

	CAC		Hs-cTnT		CAC and hs-cTnT
	CAC=0	CAC>0	<LoD	≥LoD	Hs-cTnT <LoD and CAC=0	Hs-cTnT ≥LoD and CAC=0	Hs-cTnT <LoD and CAC >0	Hs-cTnT ≥LoD and CAC >0
Overall cohort
Total (n)	3379	3370	2150	4599	1480	1899	670	2700
ASCVD events (n)	228	774	150	852	57	171	93	681
Total-person-years	45721	38491	28791	55422	20418	25304	8373	30118
Crude CVD rate per 1,000 person-years	5.0	20.1	5.2	15.4	2.8	6.8	11.1	22.6
10-year proportion with ASCVD (%) (95% CI)	3.6 (3.0-4.3)	17.5 (16.1-18.8)	4.7 (3.7-5.6)	13.2 (12.2-14.2)	2.4 (1.6-3.2)	4.6 (3.6-5.5)	9.8 (7.5-12.2)	19.4 (17.8-21.0)
Male
Total (n)	1238	1948	559	2627	328	910	231	1717
ASCVD events (n)	100	496	54	542	15	85	39	457
Total-person-years	16539	21846	7373	31011	4520	12019	2854	18992
Crude CVD rate per 1,000 person-years	6.0	22.7	7.3	17.5	3.3	7.1	13.7	24.1
10-year proportion with ASCVD (%) (95% CI)	4.1 (3.0-5.3)	19.5 (17.6-21.3)	6.0 (4.0-8.0)	15.0 (13.6-16.4)	2.0 (0.4-3.5)	4.9 (3.4-.6.3)	11.9 (7.5-16.1)	20.6 (18.5-22.6)
Female
Total (n)	2141	1422	1591	1972	1152	989	439	983
ASCVD events (n)	128	278	96	310	42	86	54	224
T otal-person-years	29183	16646	21417	24411	15898	13284	5519	11127
Crude CVD rate per 1,000 person-years	4.4	16.7	4.5	12.7	2.6	6.5	9.8	20.1
10-year proportion with ASCVD (%) (95% CI)	3.3 (2.5-4.1)	14.7 (12.8-16.7)	4.5 (3.2-5.2)	10.7 (9.3-12.1)	2.5 (1.6-3.4)	4.3 (3.0-5.6)	8.8 (6.011.5)	17.4 (14.9-19.9)